What new Medicaid rules mean for people with cancer, state by state
A public monitor of the federal rule, how each state verifies medical frailty, early enrollment data, and projected effects on cancer screening and on patients already living with cancer.
State tracker
Choose a state on the map to see where it stands, how it verifies medical frailty, and its projected screening losses. States write their own condition lists, so the same patient can be treated differently across a state line.
Federal policy
The law, the interim final rule, CMS guidance and the litigation, in order. The rule names no diagnosis; people with cancer qualify only through medical frailty, which also requires that the condition significantly impairs their ability to comply (42 CFR 435.554(c)(5)(i)).
What the rule means for a patient with cancer
- A cancer diagnosis does not exempt anyone on its own.
- States must first try to confirm frailty from the past 12 months of claims, using a condition list each state writes. Paperwork is requested only when the records fall short.
- CMS's own example: a woman in chemoradiation for stage IIIC breast cancer is confirmed from her records. A woman treated for stage IIA disease ten years ago is sent to manual review.
- Frailty must be rechecked at least every 12 months. Work or activity is checked at 6-month renewals.
- States may adopt a short-term hardship exception that covers hospital stays and travel for medical care.
Real-world outcomes
Nebraska is the first state to report data. Most people who lost coverage did so because they did not respond to a request for information, not because they were found out of compliance.
Nebraska: outcomes for people subject to the requirement
Share of each group. New applicants May–Aug 2026; renewals Jul–Aug 2026.
Behind the losses
Nebraska Medicaid Advisory Committee, 17 Sep 2026, via KFF.
Projections
Two models. The first estimates missed cancer screenings when people lose coverage. The second asks whether people already living with cancer can have their frailty confirmed from records, or must document it themselves.
Missed screenings by cancer type, 2027–2028
Base scenario with 95% intervals. Shubeck & Diaz, JAMA Oncology 2026.
| Cancer | Undetected | Advanced stage | Excess deaths |
|---|
How much depends on the scenario
Limited: 8% work-requirement coverage loss, 25% more churn. Base: 12% and 35%. Aggressive: 16% and 50%.
| Two-year total | Limited | Base | Aggressive |
|---|
People with cancer sent to manual frailty review Preliminary
Medicaid adults 19–64 with a cancer history, MEPS 2018–2024. Same patients and records; only the evidence a state counts changes.
People living with cancer on Medicaid Preliminary
Annual averages, adults 19–64 without Medicare. Under peer review.
| Group | Per year | 95% CI |
|---|
These are estimates of what records can show, not of coverage loss.
Congressional districts
In development. Each district will show expansion-adult enrollment, the projected number of people with cancer, and how many are likely to be asked for frailty paperwork under their state's rules.
Enrollment
Expansion adults by district, following the KFF method.
Cancer prevalence
National survey rates adjusted by age and sex, calibrated to state cancer registries.
State rules
Each state's coded frailty rules from the tracker above.
Research
Our studies, and the wider literature. Most analyses of the requirement do not look at cancer.
Our work
| Title | Venue | Status |
|---|
Related research
| Study | What it examined | Finding | Cancer |
|---|
Using the numbers
Suggested wording for reporters, advocates and policy staff, with the caveats each figure needs.
| Statement | Figure | Use | Caveat |
|---|